The anti-inflammatory properties of melatonin have been extensively studied also in models of sepsis in which melatonin inhibits the NF-κB pathway activation [157–159], induces the conservation of the mitochondrial homeostasis, and reduces ROS and proinflammatory cytokine production [125, 159–162]. Here, NFKB1 is linked to Sepsis.